117 related articles for article (PubMed ID: 7677997)
1. Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence.
Carroll SS; Olsen DB; Bennett CD; Gotlib L; Graham DJ; Condra JH; Stern AM; Shafer JA; Kuo LC
J Biol Chem; 1993 Jan; 268(1):276-81. PubMed ID: 7677997
[TBL] [Abstract][Full Text] [Related]
2. Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor.
Olsen DB; Carroll SS; Culberson JC; Shafer JA; Kuo LC
Nucleic Acids Res; 1994 Apr; 22(8):1437-43. PubMed ID: 7514786
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.
Reardon JE; Miller WH
J Biol Chem; 1990 Nov; 265(33):20302-7. PubMed ID: 1700787
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one.
Saari WS; Wai JS; Fisher TE; Thomas CM; Hoffman JM; Rooney CS; Smith AM; Jones JH; Bamberger DL; Goldman ME
J Med Chem; 1992 Oct; 35(21):3792-802. PubMed ID: 1279173
[TBL] [Abstract][Full Text] [Related]
5. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.
Jaju M; Beard WA; Wilson SH
J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 reverse transcriptase by a quinazolinone and comparison with inhibition by pyridinones. Differences in the rates of inhibitor binding and in synergistic inhibition with nucleoside analogs.
Carroll SS; Stahlhut M; Geib J; Olsen DB
J Biol Chem; 1994 Dec; 269(51):32351-7. PubMed ID: 7528214
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T).
Balzarini J; Pérez-Pérez MJ; San-Félix A; Camarasa MJ; Bathurst IC; Barr PJ; De Clercq E
J Biol Chem; 1992 Jun; 267(17):11831-8. PubMed ID: 1376314
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 4. 3-[2-(Benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one and analogues.
Hoffman JM; Smith AM; Rooney CS; Fisher TE; Wai JS; Thomas CM; Bamberger DL; Barnes JL; Williams TM; Jones JH
J Med Chem; 1993 Apr; 36(8):953-66. PubMed ID: 7683054
[TBL] [Abstract][Full Text] [Related]
10. Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors.
Taylor PB; Culp JS; Debouck C; Johnson RK; Patil AD; Woolf DJ; Brooks I; Hertzberg RP
J Biol Chem; 1994 Mar; 269(9):6325-31. PubMed ID: 7509800
[TBL] [Abstract][Full Text] [Related]
11. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
[TBL] [Abstract][Full Text] [Related]
12. Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors.
Condra JH; Emini EA; Gotlib L; Graham DJ; Schlabach AJ; Wolfgang JA; Colonno RJ; Sardana VV
Antimicrob Agents Chemother; 1992 Jul; 36(7):1441-6. PubMed ID: 1380789
[TBL] [Abstract][Full Text] [Related]
13. Psychotrine and its O-methyl ether are selective inhibitors of human immunodeficiency virus-1 reverse transcriptase.
Tan GT; Kinghorn AD; Hughes SH; Pezzuto JM
J Biol Chem; 1991 Dec; 266(35):23529-36. PubMed ID: 1721050
[TBL] [Abstract][Full Text] [Related]
14. Template. Phosphorothioate oligonucleotides duplexes as inhibitors of HIV-1 reverse transcriptase.
Maury G; el Alaoui A; Morvan F; Müller B; Imbach JL; Goody RS
Biochem Biophys Res Commun; 1992 Aug; 186(3):1249-56. PubMed ID: 1380799
[TBL] [Abstract][Full Text] [Related]
15. DNA chain termination activity and inhibition of human immunodeficiency virus reverse transcriptase by carbocyclic 2',3'-didehydro-2',3'-dideoxyguanosine triphosphate.
Orr DC; Figueiredo HT; Mo CL; Penn CR; Cameron JM
J Biol Chem; 1992 Feb; 267(6):4177-82. PubMed ID: 1371285
[TBL] [Abstract][Full Text] [Related]
16. A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors.
Goldman ME; O'Brien JA; Ruffing TL; Schleif WA; Sardana VV; Byrnes VW; Condra JH; Hoffman JM; Emini EA
Antimicrob Agents Chemother; 1993 May; 37(5):947-9. PubMed ID: 7685996
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus reverse transcriptase. Effect of primer length on template-primer binding.
Reardon JE; Furfine ES; Cheng N
J Biol Chem; 1991 Jul; 266(21):14128-34. PubMed ID: 1713216
[TBL] [Abstract][Full Text] [Related]
18. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.
Tramontano E; Cheng YC
Biochem Pharmacol; 1992 Mar; 43(6):1371-6. PubMed ID: 1373283
[TBL] [Abstract][Full Text] [Related]
20. Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.
Nunberg JH; Schleif WA; Boots EJ; O'Brien JA; Quintero JC; Hoffman JM; Emini EA; Goldman ME
J Virol; 1991 Sep; 65(9):4887-92. PubMed ID: 1714522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
